Compare · AGL vs ARA
AGL vs ARA
Side-by-side comparison of agilon health inc. (AGL) and American Renal Associates Holdings, Inc (ARA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AGL and ARA operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- AGL carries a market cap of $1.61B.
- AGL has hit the wire 8 times in the past 4 weeks while ARA has been quiet.
- AGL has more recent analyst coverage (25 ratings vs 0 for ARA).
- Company
- agilon health inc.
- American Renal Associates Holdings, Inc
- Price
- $95.90+2.57%
- -
- Market cap
- $1.61B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- 2016
- News (4w)
- 8
- 0
- Recent ratings
- 25
- 0
AGL
agilon health inc.
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.
Latest AGL
- agilon health to Participate in Upcoming Conferences
- Chief Accounting Officer Gertsch Timothy covered exercise/tax liability with 17 shares, decreasing direct ownership by 0.12% to 14,152 units (SEC Form 4) (withholding tax)
- Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.
- agilon health upgraded by Citigroup with a new price target
- SEC Form 10-Q filed by agilon health inc.
- agilon health inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chief Legal Officer Zamore Denise covered exercise/tax liability with 37 shares, decreasing direct ownership by 0.06% to 66,075 units (SEC Form 4) to satisfy withholding tax
- agilon health downgraded by Citigroup with a new price target
- agilon health inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest ARA
- SEC Form 15-12B filed
- SEC Form EFFECT filed
- SEC Form SC 13G/A filed
- SEC Form 4 filed by P L Partners Capital Centerbridge
- SEC Form 4: W Thomas Erickson disposed to the issuer $0 worth of Common Stock (67,755 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: J Christopher Hocevar disposed to the issuer $0 worth of Common Stock (18,679 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: A Joseph Carlucci disposed to the issuer $0 worth of Common Stock (1,245,164 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: M John Jureller disposed to the issuer $0 worth of Common Stock (49,435 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: T Syed Kamal disposed to the issuer $0 worth of Common Stock (1,291,236 units at $0.00), decreasing ownership by 100% to 0 units
- SEC Form 4: Victoria Labriola disposed to the issuer $0 worth of Common Stock (64,569 units at $0.00), decreasing ownership by 100% to 0 units